Navigation Links
Cholesterol Drugs May Raise Post-Op Delirium Risk
Date:9/22/2008

Patients on statin medications 30% more likely to experience trouble, study finds

MONDAY, Sept. 22 (HealthDay News) -- People who are taking cholesterol-lowering statin drugs -- which include Crestor, Lipitor, Pravachol and Zocor -- are more likely to suffer delirium after surgery, a Canadian study indicates.

Delirium is a common, and commonly neglected, experience for older people after any sort of surgery, according to study lead author Dr. Donald A. Redelmeier, professor of medicine at the University of Toronto.

"It's quite striking how some people are unable to recognize family members and don't know where they are," Redelmeier said. "It is sometimes prolonged and severe."

His team published its findings in the Sept. 23 issue of the Canadian Medical Association Journal.

The study included more than 284,000 people, 65 years of age and older, who had surgery in Ontario hospitals. The researchers reported that the incidence of delirium was 1 out of every 90 patients, but it was 30 percent more likely to occur in those taking statins before surgery.

These statistics are almost certainly too low, however, because "there is no question that delirium is often overlooked by the surgeon or family members or even the patient himself," Redelmeier said.

His estimate is that delirium occurs after about 10 percent of all surgical procedures, and that the incidence is 13 percent among people taking statins.

Redelmeier said he looked for a possible link between statins and post-op delirium, because "all clinical trials of statins focus on otherwise healthy outpatients under normal circumstances. Whereas, from my work in hospitals, I have found that medications that are safe under normal circumstances might not be safe at the time of surgery." Blood-thinning medications such as Coumadin, as well as sleeping pills, are other examples of drugs that raise delirium risks, he said.

Statins might increase the risk of delirium by shunting blood away from the brain to the heart, the report proposed. "It is plausible, but there are no biological data to support it," said one expert, Dr. Edward R. Marcantonio, associate professor of medicine at Harvard Medical School and the author of an accompanying editorial.

Marcantonio was also cautious about stopping statin therapy before surgery. "Before making a change in clinical management, I usually like to see stronger evidence in doing so," he said.

Marcantonio cited other factors that argued against stopping statins. "We certainly don't know the effect of taking patients off these drugs on outcomes other than delirium, such as cardiovascular conditions," he said. "They may have cardiovascular benefits above and beyond their lipid-lowering effects."

And, Marcantonio said, "There is always the risk of the drug never getting restarted."

Redelmeier has no such doubts. An internist, he does not do surgery himself but is often called in for consultation by surgeons. "I take the position that a brief interruption, for one or two days prior to surgery, is extremely simple, and if desired, you could restart the statin right there in the recovery room after surgery, so you get protection without any interaction with anesthetics," he reasoned.

More study is needed to settle the issue, Marcantonio said, and such a study would use better tools than those in the new report. Delirium has been underreported in the past because of reliance on reviews of medical records "or even abstraction into databases," he said. "One of the real advances has been development of interview tools to enable assessment of delirium in a reliable way."

Marcantonio has done such studies himself. "It is an expanding area of research -- ongoing studies of delirium where data may be available to do this sort of evaluation," he said. "Certainly, such a study is doable, perhaps within a couple of years."

More information

For more on statins, head to the National Heart, Lung, and Blood Institute.



SOURCES: Donald A. Redelmeier, M.D., professor, medicine, University of Toronto, Ontario, Canada; Edward R. Marcantonio, M.D., associate professor, medicine, Harvard Medical School, Boston; Sept. 23, 2008, Canadian Medical Association Journal


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discoverers of Small Regulatory RNAs and Cholesterol-Lowering Drugs to Receive Lasker Awards for Medical Research
2. September 2008 Mayo Clinic Womens HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol
3. Cholesterol Awareness Month: Americans Urged to Seek Early Intervention
4. Lipid Association Responds to New Cholesterol Guidelines for Children
5. Fish oil and red yeast rice studied for lowering blood cholesterol
6. Pediatricians Recommend Cholesterol Drugs for Some Kids
7. Gene variants linked to metabolic syndrome and HDL cholesterol levels
8. Nutrition 21 Launches Iceland Health(R) Cholesterol Health and Iceland Health(R) Joint Relief Plus SLEEP Support
9. Blood cholesterol levels predict risk of heart disease due to hormone therapy
10. Cholesterol Test Spots When HRT Raises Heart Risks
11. Oxidized LDL Cholesterol Linked to Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol Drugs May Raise Post-Op Delirium Risk
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
Breaking Medicine Technology: